Adherence to Treatment in Severe Asthma: Predicting Factors in a Program for Asthma Control in Brazil

World Allergy Organization Journal

Álvaro A Cruz¹  Pablo Moura Santos¹  Adelmir Souza-Machado¹ 

[1] The Instituto de Ciências da Saúde, ProAR, Hospital Universitário Professor Edgar Santos, and ProAR, Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Bahia, Brazil

关键词: treatment;    severe;    predictors;    asthma;    adherence;   

Others  :  1180792
DOI  :  10.1097/WOX.0b013e3181d25e8e

【 摘 要 】

Background

In Brazil, like many other low- to middle-income countries, most asthmatic patients cannot afford the medication necessary to prevent exacerbations. The reference clinic of the Programme for Asthma Control in Bahia (ProAR; Salvador-Bahia) offers free medical care, pharmaceutical assistance (inhaled medication) and patient education. The reference clinic is accessible to all the population of Salvador and the Programme is targeted on severe asthma.

Objective

The aim of the present study was to evaluate adherence to inhaled medication in severe asthmatics enrolled in ProAR.

Methods

A sub-group of 160 consecutive severe asthmatics enrolled in ProAR were followed prospectively for 6 months. All patients were assessed by means the Asthma Control Questionnaire, the Beck Depression Inventory and spirometry. The rate of adherence to inhaled corticosteroid was checked monthly. A cut-off point of 80% of the doses prescribed in the period was used to define patients as adherent.

Results

Of the one hundred-sixty patients with severe asthma included, it was possible to objectively assess adherence to the use of the inhaled corticosteroid in 158. Among these, 112 (70.9%) were considered adherent according to the adopted cut-off point. The rate of adherence in the whole sample of subjects was 83.9% of the prescribed doses. There was a significant association between asthma control and adherence to treatment. Predictors of poor adherence were adverse effects, living far from the referral center, limited resources to pay for transportation and dose schedule.

Conclusion

In the present study, adherence to treatment was high. In a sample of patients with severe asthma managed in a public program that provides free medication and multidisciplinary treatment at a referral center, adherence to treatment was found to be associated with favorable clinical outcomes.

【 授权许可】

   
2010 World Allergy Organization; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Global strategy for asthma management and prevention: Global Initiative for Asthma (GINA); 2008. [http://www.ginasthma.org] webcite 2009. Updated 2008, Accessed May 7
• [2]World Health Organization: Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. [http://www.who.int/topics/patient_adherence/en] webcite 2009. Accessed May 7
• [3]Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, Mac-Donald TM: Primary non-compliance with prescribed medication in primary care. BMJ 1993, 307:846-848.
• [4]Chatkin JM, Cavalet-Blanco D, Scaglia NC, Tonietto RG, Wagner MB, Fritscher CC: Compliance with maintenance treatment of asthma (ADERE study). J Bras Pneumol 2006, 32:277-283.
• [5]Nagy VT, Wolfe GR: Cognitive predictors of compliance in chronic disease patients. Med Care 1984, 22:912-921.
• [6]Cluley S, Cochrane GM: Psychological disorder in asthma is associated with poor control and poor adherence to inhaled steroids. Respir Med 2001, 95(1):37-39.
• [7]Santos Pde M, D'Oliveira A Jr, Noblat Lde A, Machado AS, Noblat AC, Cruz AA: Predictors of adherence to treatment in patients with severe asthma treated at a referral center in Bahia, Brazil. J Bras Pneumol 2008, 34(12):995-1002.
• [8]Osterberg L, Blaschke T: Drug therapy: adherence to medication. N Engl J Med 2005, 353:487-497.
• [9]Ponte E, Franco RA, Souza-Machado A, Souza-Machado C, Cruz AA: Impact that a program to control severe asthma has on the use of Unified Health System resources in Brazil. J Bras Pneumol 2007, 33:15-19.
• [10]Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR: Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999, 14(4):902-907.
• [11]Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-71.
• [12]Rand CS, Wise RA: Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med 1994, 149(2 Pt 2):S69-S76. discussion S77-S78
• [13]Nagy VT, Wolfe GR: Cognitive predictors of compliance in chronic disease patients. Med Care 1984, 22:912-921.
• [14]Adeyeye OO, Onadeko BO: Understanding medication and use of drug delivery devices by asthmatics in Lagos. West Afr J Med 2008, 27(3):155-159.
• [15]Cochrane GM: Compliance and outcomes in patients with asthma. Drugs 1996, 52(Suppl 6):12-19.
• [16]Goldney RD, Ruffin R, Fisher LJ, Wilson DH: Asthma symptoms associated with depression and lower quality of life: a population survey. Med J Aust 2003, 178:437-441.
• [17]Mancuso CA, Rincon M, McCulloch CE, Charlson ME: Self-efficacy, depressive symptoms, and patients' expectations predict outcomes in asthma. Med Care 2001, 39:1326-1338.
• [18]Agertoft L, Pedersen S: A randomized, double blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. J Allergy Clin Immunol 1997, 99:773-780.
• [19]Self TH, Arnold LB, Czosnowski LM, Swanson JM, Swanson H: Inadequate skill of healthcare professionals in using asthma inhalation devices. J Asthma 2007, 44(8):593-598.
• [20]Claxton AJ, Cramer J, Pierce C: A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001, 23(8):1296-1310.
• [21]Bosley CM, Fosbury JA, Cochrane GM: The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J 1995, 8(6):899-904.